Become A Featured Company

The Pros and Cons of Medical Marijuana

Lukas Barfield

October 26th, 2017

Policy

blank form for the pros and cons, black and white image

Throughout recorded history the cannabis sativa plant was used for recreation, fiber and medicine. It wasn’t until the 20th century that the much maligned marijuana plant earned its negative reputation on a worldwide scale.

The issue of so called “Indian Hemp” was seriously addressed for the first time on a global scale at the 2nd Opium Conference in Geneva of 1925. At the conference, it was agreed upon that “Indian Hemp” would be put on the list of drugs that were to be monitored by governments around the world. The United States did not sign the agreement, but later passed its own restrictions on marijuana in 1937 with the passage of the Marijuana Stamp Tax Act.

This unfortunate intervention by governments around the world has proven to be the primary factor that has hampered research into marijuana’s efficacy as a viable medicine. In spite of government efforts to impede research, some investigations have shown marijuana to be an effective medicine for treating a variety of conditions. However, it’s illegality on a Federal level and in most industrialized countries still has consequences.

Therefore, patients must carefully way the “Pros” and “Cons” of using medical marijuana to treat their individual conditions. Due to lack of information, this decision may not be an easy one. Here is a list of some known medical marijuana pros and cons that may help patients make such an important decision.

Pros of Medical Marijuana

  • Marijuana is an extremely safe medicine. There has been no known overdose from marijuana, there are few side effects and it is not physically addictive.
  • Marijuana is a very versatile medicine as it interacts directly with the endocannabinoid system, a system in the body which promotes balance in the cells. The resin produced by the marijuana plant can be made into innumerable products that can be used to treat many different medical conditions affecting all parts of the body and for which pharmaceuticals may not be effective.
  • Patients can grow their own medical marijuana. Depending on which state you live in, many medical marijuana patients have the option of growing their own medicine. Growing outdoors can provide larger amounts for patients once a year, but indoor gardens work well for a consistent supply of medicine year round.
  • Much of the United States has medical marijuana laws. Twenty-nine states plus DC have medical marijuana, eight states and DC have legal adult use recreational marijuana, and many other states have high CBD regulations. These well-regulated state-run medical marijuana systems provide safe medical marijuana to patients, and more states are passing medical marijuana laws every year.

Cons of Medical Marijuana

  • The Federal Drug Administration does not regulate marijuana products, due to marijuana’s designation as a Schedule 1 Narcotic, a “controlled substance”, with no known medical use. This means patients are often left to their own devices determining which medical marijuana products are effective.
  • Dosing marijuana can be an issue. Despite its versatility, due to lack of research, little is known about affective medical marijuana dosing. The Mayo Clinic does provide loose guidelines for some conditions, but little is known about the exact amount of medical marijuana needed to treat a given ailment.
  • Insurance does not cover medical marijuana. As a result, costs can rise when treating conditions such as cancer or MS for which larger amounts of medical marijuana are required.
  • Marijuana is still illegal on a Federal level, and still in a handful of states. Although marijuana has been decriminalized in many municipalities around the country, patients living outside legal Medical marijuana states may still face prosecution for possessing medical marijuana. In addition, many jobs still drug test for marijuana, and in some states testing positive for marijuana may affect transplant eligibility.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Lukas Barfield

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading